Clinical & Institutional
Hospitals, polyclinics, academic medical centres, genomics labs, pharmaceutical companies, and CROs across Saudi Arabia.
SmartCheck helps Saudi clinics run cleaner intake, coverage checks, and handoffs to care, with PDPL and in-Kingdom residency in mind.
Outcomes clinics feel on the floor: cleaner records at arrival, fewer coverage surprises, and claims that move with less rework.
SmartCheck covers clinic operations. The biomedical data products serve hospitals, labs, and research. Both run on the same in-Kingdom stack.
Hospitals, polyclinics, academic medical centres, genomics labs, pharmaceutical companies, and CROs across Saudi Arabia.
Longevity clinics, precision wellness brands, personalized cosmetics, and DTC genomics platforms with digital intake journeys.
SmartCheck focuses on the moments that waste time and revenue in Saudi clinics: arrival, coverage, the consult handoff, and the claim that follows.
Four pressure points on the patient journey. Ask for a demo to walk the full workflow.
Patients enter with fewer gaps. Staff spend less time fixing the record before care begins.
Issues surface before they disrupt the visit, not after the claim comes back.
Physicians open the encounter with context already structured. Less hunting, more care.
Fewer rework loops between care and finance. Revenue catches up to the visit.
Risk, genomics, multi-omics, and pharmacovigilance on the same in-Kingdom backbone as SmartCheck.
Continuous risk stratification for Saudi hospital wards, with clinician-ready attribution.
VCF, WES, and WGS transformed into clinician-readable reports.
Visual no-code pipelines for multi-omics analysis across research and care.
Drug safety case handling and signal analysis for hospital and pharma teams.
Vision 2030 is pushing hospitals, genomics programs, and clinic automation forward at the same time. AIDARA is built for that stack, in-Kingdom.
Why now: Vision 2030 is raising demand for clinical intelligence and cleaner patient operations. AIDARA covers both on one in-Kingdom platform.
SmartCheck lands in intake, coverage, and claims first, so buyers see floor-level outcomes before committing to deeper data products.
The same in-Kingdom backbone runs clinic automation and biomedical data products, so hospital groups do not buy two disconnected vendors.
PDPL, NPHIES, and in-Kingdom residency sit in the product path, not as a later compliance bolt-on.
For hospital groups and clinic networks ready to evaluate SmartCheck and the data platform. Outcomes and architecture are shared in a private briefing under NDA.